This scanning method could become a simple, completely non-invasive method of early Alzheimer’s detection, according to the researchers, and also has potential as a way to assess the effectiveness of treatment.
VA signed a memorandum of agreement with the National Institute of Allergy and Infectious Diseases (NIAID) on June 28 to expand collaborative research.